A. Lépinoy, Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy, Radiother. Oncol, vol.111, issue.1, pp.120-125, 2014.

A. Wahart, Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation, Br. J. Radiol, vol.89, issue.1058, p.20150579, 2016.

W. P. Parker, Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography, Int. J. Radiat. Oncol. Biol. Phys, vol.97, issue.3, pp.526-535, 2017.

J. J. Tosoian, M. A. Gorin, A. E. Ross, K. J. Pienta, P. T. Tran et al., Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations, Nat. Rev. Urol, vol.14, issue.1, pp.15-25, 2017.

P. Ost, Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial, J. Clin. Oncol, vol.36, issue.5, pp.446-453, 2018.

U. Schick, Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases, Acta Oncol, vol.52, issue.8, pp.1622-1628, 2013.

M. Picchio, C-Choline PET/CT as a guide to radiation treatment planning of lymphnode relapses in prostate cancer patients, Eur. J. Nucl. Med. Mol. Imaging, vol.41, issue.11, pp.1270-1279, 2014.

A. Fodor, Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer, BJU Int, vol.119, issue.3, pp.406-413, 2017.

G. Créhange, Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?, Cancer Radiother, vol.18, issue.5-6, pp.524-534, 2014.

A. Goineau, Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer, Radiat. Oncol, vol.8, p.53, 2013.

A. Bayley, Clinical Application of High-Dose, Image-Guided Intensity-Modulated Radiotherapy in High-Risk Prostate Cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.77, issue.2, pp.477-483, 2010.

J. B. Adkison, Phase I Trial of Pelvic Nodal Dose Escalation With Hypofractionated IMRT for High-Risk Prostate Cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.82, issue.1, pp.184-190, 2012.

M. R. Ferreira, Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.99, issue.5, pp.1234-1242, 2017.

B. A. Jereczek-fossa, Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.82, issue.2, pp.889-897, 2012.

K. Decaestecker, Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence, Radiat. Oncol, vol.9, p.135, 2014.

T. Zilli, E. Benz, G. Dipasquale, M. Rouzaud, and R. Miralbell, Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance, Int. J. Radiat. Oncol. Biol. Phys, vol.96, issue.2, pp.318-322, 2016.

A. Sujenthiran, National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.99, issue.5, pp.1253-1260, 2017.